Search Results for "New Treatment For Hepatitis B"

22:12 EST 25th February 2017 | BioPortfolio

Matching Channels

Hepatitis B

Hepatitis A

Hepatitis C

Most hepatitis C virus (HCV) infected individuals seeking treatment are chronically infected. Treatment goal is to achieve a sustained virological response (SVR), which is the absence of serum HCV R...

Hepatitis E virus HEV

Hepatitis B virus HBV

Matching News

Warning: Reactivation of Hepatitis B Virus Coinfection During Treatment of Chronic Hepatitis C Virus Infection

SYNOPSIS: Prior to initiation of hepatitis C virus treatment with direct-acting antivirals, patients should be screened for hepatitis B virus coinfection. Those who are hepatitis B virus-infected shou...

Hepatitis C Treatment Continues to Amaze; Need to Screen Baby Boomers

Regarding the treatment of hepatitis C, I confess that I have been distracted in recent months by the controversy surrounding the cost of treatment and not paid sufficient attention to the incredible ...

Hepatitis C

Learning Objectives: 1. Understand the six genotypes related to hepatitis C virus (HCV). 2. List the medications and treatment options for the 6 genotypes of HCV. 3. Describe the testing for HCV a...

Provisional NICE recommendation for Gilead’s Hepatitis C treatment

NICE has issued provisional guidance recommending the use of Gilead Sciences’ Epclusa (sofosbuvir 400 mg/velpatasvir 100 mg) for the treatment of adult chronic hepatitis C genotype 1-6 patients in E...

Hepatitis C Treatment: Issues for the Emergency Physician

This issue is written to provide you with the knowledge to be able to ask and educate patients with hepatitis C about the highly effective treatment available for most all infected patients.

AbbVie's hepatitis C treatment under accelerated review by EMA

The European Medicines Agency (EMA) has validated AbbVie's marketing authorization application (MAA) for a new hepatitis C treatment.

AbbVie's hepatitis C treatment shows promise

Nov 11 (Reuters) - Drugmaker AbbVie Inc said on Friday its experimental fixed-dose combination to treat certain hepatitis C virus patients achieved high sustained viral response (SVR) rates after eigh...

Dismal Arithmetic of Hepatitis C Treatment?

The American Journal of Managed Care has an interesting special issue on treatment for the hepatitus C virus (HCV).  Jay Bhattacharya provides the introductory commentary, and starts off with the fo...

Matching PubMed Articles

Antiviral treatment and liver-related complications in hepatitis delta.

Hepatitis delta is the most severe form of viral hepatitis. Pegylated interferon alfa (PEG- IFNα) is effective in only 25-30% of patients and is associated with frequent side effects. The aim of this...

Update on Hepatitis C treatment: Systematic review of clinical trials.

Chronic Hepatitis C is a major public health problem. The chronicity of the Hepatitis C can lead to advanced liver disease, cirrhosis and even hepatocellular carcinoma. Chronic hepatitis C is the lead...


Occult hepatitis B infection is characterized by negative hepatitis B surface antigen (HBsAg) and also detectable hepatitis B virus (HBV) -DNA, with or without hepatitis B core antibody (anti-HBc). HB...

On-treatment quantitative hepatitis B e antigen predicted response to nucleos(t)ide analogues in chronic hepatitis B.

To investigate potential predictors for treatment response to nucleos(t)ide analogues (NAs) in hepatitis B e antigen (HBeAg)-positive chronic hepatitis B (CHB) patients.

Serum hepatitis B core antibody titer use in screening for significant fibrosis in treatment-naïve patients with chronic hepatitis B.

Previous studies have revealed that hepatitis B core antibody (anti-HBc) levels vary throughout the different phases of treatment-naïve chronic hepatitis B (CHB) patients and can be used as a predict...

Search Whole site using Google

Quick Search
Advertisement Advertisement